15 January 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on three medicines.

Burosumab (Crysvita) was accepted for treating children (aged one to seventeen years), with X-linked hypophosphataemia.

Read SMC press release